- Report
- January 2025
- 180 Pages
Global
From €4012EUR$4,500USD£3,496GBP
- Report
- January 2025
- 180 Pages
Global
From €4012EUR$4,500USD£3,496GBP
- Report
- December 2024
- 180 Pages
Global
From €4012EUR$4,500USD£3,496GBP
- Report
- October 2025
- 184 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- October 2025
- 183 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- October 2025
- 191 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- October 2025
- 187 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- October 2025
- 196 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- August 2025
- 199 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- August 2025
- 191 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- August 2025
- 185 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- October 2025
- 287 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 274 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 138 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 373 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 294 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 378 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 385 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 605 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- September 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP

The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more